New research indicates that people who come off new weight-loss injections like semaglutide or tirzepatide tend to recover reduced body mass much more quickly than those who stop traditional lifestyle plans.
Findings released in a leading health publication points out that while overweight people often shed about a fifth of their body weight while undergoing treatment, the mass is regained at an average rate of 0.8 kg per month after stopping.
"People buying these treatments must be informed of the danger of rapid rebound weight gain when the medication is stopped," stated researcher Dr. Susan Jebb.
That rate of regain suggests a return to starting weight in about one and a half years.
Analyzing Therapies
The analysis, which reviewed dozens of studies involving thousands of participants, compared the outcomes of the injectable medications with older methods.
Scientists point out that individuals who shed pounds through diet and exercise generally see a slower creep back—approximately 0.1 kg a month—post-intervention.
Understanding the Quick Rebound
Experts suggest the mode of action of the injections accounts for the amplified rebound.
GLP-1 drugs mimic a body's own chemical called glucagon-like peptide-1, which moderates feelings of fullness.
"Artificially providing the hormone concentrations several times higher than the body's typical production could lead to the body to generate a reduced amount of its own natural hormone, and may also lessen sensitivity to its actions," explained Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this hormone supplement means appetite is uncontrolled, making excessive eating a significant risk."
A Lifelong Disease?
Health authorities suggest the injections for people with weight-linked health risks, accompanied by prescribed diet and exercise modifications.
A number of clinicians argue that, given the likelihood of relapse, the therapy might need to be ongoing.
This view is supported by drug manufacturers, who state that the results "emphasize the chronic character of excess weight," akin to managing conditions like high blood pressure.
User Testimonies
People who have come off the medication report a sudden resurgence of appetite.
"I experienced a trigger flipping and you're instantly starving," described a patient.
This challenge is compounded if patients have not developed permanent lifestyle or habit modifications during treatment.
Growing Interest
Survey data suggest that a significant number of adults in the UK have tried these injections in the past year, with desire being substantial.
- Adoption is higher among females than men.
- The middle-aged age group shows the highest usage rates.
- Many access the medications through private healthcare rather than the NHS.
Ultimately, clinicians caution that while these medications are potent agents for weight loss, they are not a magic fix and lasting health benefits hinges on combined lifestyle management.
